Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Altimmune Inc (NQ: ALT ) 7.200 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 7.200 Bid (Size) 6.810 (1) Ask (Size) 7.390 (1) Prev. Close 7.200 Today's Range 7.200 - 7.200 52wk Range 2.090 - 14.84 Shares Outstanding 70,895,286 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains April 24, 2024 These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly. Via InvestorPlace Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs? April 22, 2024 The GLP-1 weight loss trend continues to flourish, and the ante keeps rising; see how the winner between Wegovy and Zepbound can help your portfolio Via MarketBeat Performance YTD -31.56% -31.56% 1 Month -16.76% -16.76% 3 Month -22.41% -22.41% 6 Month +210.34% +210.34% 1 Year +37.93% +37.93% More News Read More Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential April 20, 2024 Via The Motley Fool 3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024 April 11, 2024 Via InvestorPlace Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead. April 09, 2024 Via The Motley Fool How Is The Market Feeling About Altimmune? April 08, 2024 Via Benzinga If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today April 03, 2024 Via Benzinga ALT Stock Earnings: Altimmune Beats EPS for Q4 2023 March 27, 2024 Via InvestorPlace Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? April 09, 2024 Via MarketBeat Exposures Product Safety Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 28, 2024 Via Benzinga Altimmune's Earnings Outlook March 26, 2024 Via Benzinga (ALT) - Analyzing Altimmune's Short Interest March 22, 2024 Via Benzinga Here's How Much $100 Invested In Altimmune 5 Years Ago Would Be Worth Today March 18, 2024 Via Benzinga REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday March 28, 2024 Via Benzinga Stock Market Rally Shows Breadth As Leaders Take A Breath: Weekly Review March 28, 2024 Via Investor's Business Daily 7 Stocks That Will Drive the Weight Loss Drugs Market March 28, 2024 Via MarketBeat Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday? March 27, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 27, 2024 Via Benzinga Earnings Scheduled For March 27, 2024 March 27, 2024 Via Benzinga Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On' March 19, 2024 Via Benzinga Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market? March 15, 2024 Via The Motley Fool ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT March 03, 2024 Via NewMediaWire ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT March 03, 2024 Via TheNewswire.com ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT March 01, 2024 Via NewMediaWire ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT March 01, 2024 Via TheNewswire.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.